Pharmacogenomic assessment of herbal drugs in affective disorders

[Display omitted] •Affective disorders like anxiety and depression are affecting a large population.•There is an increase in demand for herbal medicines for affective disorders.•Herbal drugs are facing acceptance issues due to lack of scientific evidence.•Omic technologies provide a platform for tho...

Full description

Saved in:
Bibliographic Details
Published inBiomedicine & pharmacotherapy Vol. 109; pp. 1148 - 1162
Main Authors Sahoo, Swati, S., Brijesh
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.01.2019
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •Affective disorders like anxiety and depression are affecting a large population.•There is an increase in demand for herbal medicines for affective disorders.•Herbal drugs are facing acceptance issues due to lack of scientific evidence.•Omic technologies provide a platform for thorough evaluation of herbal drugs. Anxiety and depression, the most prevalent psychiatric disorders are co-morbid in nature affecting several people across the world. There is an increase in demand for complementary and alternative medicines, specifically herbal botanicals due to various side effects exhibited by conventional drugs. Herbal drugs mentioned in traditional medicines, face acceptance issues by the medical community due to lack of scientific data regarding their neurochemical pathways. Hence, there has been an increased interest in the quest to unravel the mechanisms of action of herbal psychotropics. With the advancements in “omic technologies” such as genomics, proteomics and metabolomics, research in the field of herbal psychopharmacology has gained momentum, providing a faster and informative platform for thorough evaluation of herbal drugs and formulations. In this article, we have reviewed several medicinal plants and their formulations that have shown potential anxiolytic and anti-depressant activities and have been screened for their biological mechanisms either at the gene, protein or metabolic level.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2018.10.135